Company Filing History:
1 out of 1,744 
1 out of 124 
1 out of 29 Years Active: 2020
Title: Pierre Cordelier: Innovator in Pancreatic Cancer Treatment Prediction
Introduction
Pierre Cordelier is a notable inventor based in Toulouse, France. He has made significant contributions to the field of medical research, particularly in the area of pancreatic cancer treatment. His innovative work has the potential to improve patient outcomes and advance cancer treatment methodologies.
Latest Patents
Pierre Cordelier holds a patent for "Methods for predicting pancreatic cancer treatment response." This invention relates to methods that can predict how patients will respond to treatments for pancreatic cancer. His work in this area is crucial for developing personalized treatment plans that can enhance the effectiveness of therapies.
Career Highlights
Throughout his career, Cordelier has been associated with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paul Sabatier (Toulouse III). His research has focused on understanding cancer biology and improving treatment strategies.
Collaborations
Pierre Cordelier has collaborated with esteemed colleagues, including Louis Buscail and Frédéric Lopez. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in cancer treatment.
Conclusion
Pierre Cordelier's contributions to the field of pancreatic cancer treatment prediction exemplify the impact of innovative research on healthcare. His work not only advances scientific knowledge but also holds promise for improving patient care in oncology.